Trial | NCT00223951  Report issue

Title

Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers
A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of R89674 0.25% Ophthalmic Solution in Healthy, Normal Volunteers

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    alcaftadine ...

  • Study Participants

    900
The purpose of this study is to evaluate the safety of R89674 0.25% ophthalmic solution in healthy normal volunteers
Study Started
Sep 30
2005
Primary Completion
Dec 31
2005
Last Update
Feb 20
2015
Estimate

Drug R89674 (generic name not yet established)

Criteria 

Inclusion Criteria:

healthy normal volunteers age >=3 years with normal ocular health and a best-corrected logMAR score of 0.3 or better

-

Exclusion Criteria:

intraocular surgery and/or ocular surgical intervention within last 3 months, refractive surgery within last 6 months, active ocular disorder other than refractive disorders, breastfeeding women, pregnant female < 18 years of age -
No Results Posted